Midodrine During Recovery From Septic Shock

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2017

Primary Completion Date

November 1, 2017

Study Completion Date

November 1, 2017

Conditions
HypotensionShock, SepticSepsis
Interventions
DRUG

Midodrine

midodrine is metabolized to an active metabolite, desglymidodrine, which is an alpha adrenergic antagonist that causes vasoconstriction of both venous and arterial vasculature, thereby increasing blood pressure

DRUG

placebo

placebo will be administered to double blind the study

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Northwell Health

OTHER